RudaCure, a bioventure company developing treatments for intractable diseases, held a accord de transfert de technologie signing ceremony with Hanlim Pharmaceutical Co., Ltd., a mid-sized company developing national ophtalmique disease treatments, on the 13th for the ulcère cornéen and traitement des lésions cornéennes RCI001U.
RCI001U is a pipeline derived from the existing traitement de la sécheresse oculaire RCI001, and has demonstrated superior lésions cornéennes healing effects compared to existing corneal treatments. Grâce à cela accord, RudaCure provides Hanlim Pharmaceutical with national production and sales rights to the technology and receives étape clé payments notamment approbation d'essai cliniques.
Given the current absence of national drugs for traitement des lésions cornéennes, RudaCure's RCI001U is being transferred after completing third-party confirmatory efficacy testing along with études toxicologiques non cliniques. It is expected that RudaCure and its strategic partner Hanlim Pharmaceutical will be able to respond swiftly to the traitement des lésions cornéennes market where drugs are actuellement absent.
RudaCure had already completed the national transfert de technologie of the traitement de la sécheresse oculaire RCI001 to Hanlim Pharmaceutical in April 2021, and by executing this additional indication development accord, the network between the two companies has been further strengthened. À l'avenir, it is expected that continuous collaboration will be pursued not only for sécheresse oculaire and traitement des lésions cornéenness, but also for the development of divers ophtalmique treatments notamment ocular implants for macular degeneration treatment.
메디팜헬스 http://www.medipharmhealth.co.kr/news/article.html?no=88169 헬스코리아 뉴스 https://www.hkn24.com/news/articleView.html?idxno=331344 메디파나 https://www.medipana.com/article/view.php?news_idx=307266&sch_cate=D팜뉴스 https://www.pharmnews.com/news/articleView.html?idxno=217143
헤럴드경제 http://news.heraldcorp.com/view.php?ud=20230116000105
메디소비자뉴스 http://www.medisobizanews.com/news/articleView.html?idxno=103851
데일리팜 http://www.dailypharm.com/Users/News/NewsView.html?ID=296092
약업신문 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=277798
